Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. - Wikidata - wikimedia - TriplyDB

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

http://www.wikidata.org/entity/Q44647903

about

Antiretroviral resistance testing in treatment-naïve people living with HIV Antiretroviral resistance testing in treatment-naive HIV-infected adults Antiretroviral resistance testing in treatment-naive HIV-infected adults Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time "Dynamic range" of inferred phenotypic HIV drug resistance values in clinical practice The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients From practice guidelines to clinical decision support: closing the loop Initiation of antiretroviral therapy.Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1.Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision Genotypic testing for human immunodeficiency virus type 1 drug resistance.Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.Comparing computer-interpretable guideline models: a case-study approach The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations.The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada.Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates.Clinical management of HIV drug resistance.The Brazilian network for HIV-1 genotyping external quality control assurance programme.Genotype, phenotype, and virtual phenotype: who needs what and why?Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.Recent advances in the treatment of HIV/AIDS.Prevalence of and viral outcomes associated with primary HIV-1 drug resistance Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients.Bioinformatics approach to predicting HIV drug resistance.Predictive value of HIV-1 genotypic resistance test interpretation algorithms.HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation.Clinical decision support for genetically guided personalized medicine: a systematic review Molecular assays for monitoring HIV infection and antiretroviral therapy.Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study

P2860

Q24186997-7F33141B-880D-4A48-B4B8-3376A57339A4 Q24198919-CFEF8B6C-AFA7-4C9D-92A7-F3925CE04A14 Q24240372-04964018-06F7-4A27-B5D3-91CE7D819FB3 Q24243499-CC4A11D8-B0E3-4F75-BD62-E75E6F132066 Q28471687-5B8E7094-0047-4FFB-AA3D-3CA4025B7E3B Q28474806-42DF44D5-F19A-419E-A115-97C570672978 Q28477270-C986928B-E58E-451A-B4C7-A74D35DB15DC Q28536153-C3BACE55-A9E1-4E23-87C5-F5208569154B Q28750318-D50E41DE-1A6C-45C5-959D-C1093B3682D6 Q30209635-1E484780-DCD7-44C9-B4F4-A3604B484F96 Q33672541-AF4FE101-D9C9-4B52-AD09-C47CCD3CBA39 Q33780566-34B17129-647E-4D51-AFF2-284D43C725C0 Q33836938-F844E1F9-141E-4310-AE82-2DAB9BB7216E Q33906239-A1759FB0-A86F-4E88-8FEE-29B27CA0185F Q34084316-3CC7BDCE-DDCA-4398-ADCD-250F98CD2881 Q34321843-140F6C30-A5BA-48C2-A0E7-E396C86F1BCA Q34331628-387E1972-574B-460F-B2F8-CF01A2B18AFE Q34352000-5D8F6A90-A324-487E-B8F4-2CF73D005B0B Q34518299-EC102271-AA75-4708-B14B-41E3963F6078 Q34547116-053B70BA-B658-4F88-BDA8-B2EB3035BE2C Q34775629-09EEDDD2-D861-40E6-8C60-156557AB61BC Q34777454-1849CFEE-EA30-4809-94CA-77ABA7DB7D7A Q35129194-F6C34188-9C1A-4443-BB37-14735E208355 Q35152768-47B1189C-4FD3-4D3A-BD83-42978D95884B Q35156231-5B0D909B-7603-467A-99A1-5800A54E2BEA Q35156392-125A70D9-8ED9-4A4E-A358-049E7D7DE10C Q35261045-69D55C19-784F-4645-AA8A-12FCF1150B61 Q35338638-17987CC9-0F20-4DEA-AC65-8ACA9C28FF09 Q35676512-2A2316F6-90A0-48B9-90F4-0540E59EE4EE Q35690523-505F7278-B806-4536-887E-5D440A270D5E Q35809718-53B9068C-EA81-4A44-A820-D9283DBA7E68 Q35917365-2EF47B50-F847-46FD-8218-E1CF9D130EF2 Q36291581-4CF832CA-DBF6-4F16-BEF0-BA0CA0215433 Q36315090-EAB41D45-3DBA-4E9E-B0AA-91728FDFAFE0 Q36411681-CC1EFE77-192D-4F1D-82B7-1B76623ED8B6 Q36641563-FBA195F7-808C-4AD0-80B3-76632BD1A577 Q36765273-939B3449-A2B1-4177-8D05-34165D931D26 Q36800565-F6FB5582-2E08-4DBF-B7EF-443788CE31BB Q36816024-90B37E73-92E8-4A37-BE0D-4A1E4ACC59DA Q36860367-77CFC0A5-B83E-4057-8866-DB549BB782FA

P2860

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

http://www.wikidata.org/entity/Q44647903

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@en

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@nl

type

label

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@en

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@nl

prefLabel

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@en

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@nl

P1433

Q44647903-3B353F9F-0731-428A-A56E-A401A9387DDB

P1476

Q44647903-B2A02D93-B5F1-4142-AE55-29A1B3EAFDFE

P2093

Q44647903-1405E7DF-91CE-49F6-B7FA-211579ED28EA

Q44647903-1EFBD193-9614-49FC-90B4-B737D2ADD660

Q44647903-565D84E4-0EA0-4CC7-AF56-BDAA8FC57B78

Q44647903-71D21214-DBEB-4577-BBCF-CAC472B6B550

Q44647903-A6AB37CD-D1B5-4674-B83D-D848F8907C0E

Q44647903-C97600CC-DC0E-448C-8FB9-B4A755923196

Q44647903-C9DBB38C-E3C4-4F96-9CDB-B5C0C30AE572

Q44647903-F05C3966-D31E-4829-B34B-59FBD5430568

Q44647903-F0F75E5B-D482-4012-9FBF-DB5819E0730E

Q44647903-F30500F6-136B-4C74-A786-9F7980582C92

P304

Q44647903-1A4DDD78-1B2C-425B-AA8E-520B8B0B327E

P31

Q44647903-847331CB-C069-45DC-9A4C-A71FDC1EF339

P356

Q44647903-8E2C75A0-41DD-4B9F-95D3-C699186CB2AD

P407

Q44647903-76DB11ED-A70A-463B-905E-D7E41C61B5E5

P433

Q44647903-1BDA5DEE-37D0-472B-9006-FDF8972E7357

P478

Q44647903-F37DC60F-B8F7-4550-8040-C8F6338220AA

P50

Q44647903-4DD2E4BA-AED1-4CA1-A878-C2671BB7BF19

P577

Q44647903-4A8B805F-8EB8-49D9-8993-5740C82B739B

P5875

Q44647903-6BC4048E-D916-4650-838C-8E8883AFF549

P698

Q44647903-7AA73DE7-4510-43D0-B16E-99008E8312EE

P356

00002030-200201250-00010

P1433

P1476

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

@en

P2093

C Rey-Joly

http://www.w3.org/2001/XMLSchema#string

Charles Boucher

http://www.w3.org/2001/XMLSchema#string

Christopher Holtzer

http://www.w3.org/2001/XMLSchema#string

Cristina Tural

http://www.w3.org/2001/XMLSchema#string

Havana Study Group

http://www.w3.org/2001/XMLSchema#string

Jonathan Schapiro

http://www.w3.org/2001/XMLSchema#string

Juan González

http://www.w3.org/2001/XMLSchema#string

Lidia Ruiz

http://www.w3.org/2001/XMLSchema#string

Pere Domingo

http://www.w3.org/2001/XMLSchema#string

Pompeyo Viciana

http://www.w3.org/2001/XMLSchema#string

P304

209-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00002030-200201250-00010

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Bonaventura Clotet Sala

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11552516

http://www.w3.org/2001/XMLSchema#string

P698

11807305

http://www.w3.org/2001/XMLSchema#string